LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article: Creeping Through the Backdoor: Disruption in Medicine and Health.

    Shaw, Brendan / Chisholm, Orin

    Frontiers in pharmacology

    2020  Volume 11, Page(s) 818

    Abstract: Can disruption happen when no one notices? Disruptive technologies and processes are fundamentally starting to up-end how medicines and health systems benefit patients but the question is whether health systems are ready for them. This paper will briefly ...

    Abstract Can disruption happen when no one notices? Disruptive technologies and processes are fundamentally starting to up-end how medicines and health systems benefit patients but the question is whether health systems are ready for them. This paper will briefly review the business strategy and management literature on topics such as disruption and "black swan" theories of change, before turning to discuss some of the areas where change is affecting medicine and healthcare. Such areas include the emergence of cell and gene therapies, the economics of cures, digital technologies, mobile apps, social media, supply chain technologies such as drones and online distribution, universal health coverage and funding, and consumerisation of healthcare. The question to be asked is whether these sorts of changes are "disruptive" or whether they were coming for a long time and it is just that health systems are slow to change. It could be argued that while perhaps unexpected by day-to-day practitioners in healthcare, in fact, many of the changes now starting to affect the health and medicines sector have been affecting other sectors such as technology, finance and communications for decades.
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2020.00818
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Talkin' About a Resolution: Issues in the Push for Greater Transparency of Medicine Prices.

    Shaw, Brendan / Mestre-Ferrandiz, Jorge

    PharmacoEconomics

    2020  Volume 38, Issue 2, Page(s) 125–134

    Abstract: At the 2019 World Health Assembly, a significant new resolution was agreed by most countries to start publicly sharing information on the real net prices they pay for medicines in their health systems. The resolution also includes provisions for ... ...

    Abstract At the 2019 World Health Assembly, a significant new resolution was agreed by most countries to start publicly sharing information on the real net prices they pay for medicines in their health systems. The resolution also includes provisions for countries to support other transparency activities. However, an additional proposal to require pharmaceutical companies to submit information on their internal sales figures, internal research and development costs, clinical trial costs and marketing costs for each individual medicine as a condition of registration, and for governments to publish this, was not agreed. Pressure for coordinated international action to increase the transparency of medicine prices and costs has been building for some time, as confidential discounts and rebates on prices of medicines are common. We argue that while it is possible that stakeholders may benefit to some extent from greater transparency on prices, several important policy and economic issues need to be carefully considered. Such transparency, combined with widespread use of international reference pricing, might undermine companies' differential pricing strategies, which are important in fostering wider access to medicines in low- and middle-income countries in particular, noting that access to medicines issues can occur in high-income countries as well. Moreover, there is a further risk that these types of proposals will lead to price fixing, less competition and higher prices than might otherwise be the case. The lack of any commitments in the resolution to greater transparency in payer decision-making processes also risks undermining the credibility of the resolution. The resolution and further transparency measures could have the potential to undermine patient access to medicines in the developing world, lead to higher prices in some markets and compromise long-term development of new medicines for future generations.
    MeSH term(s) Cost Control/legislation & jurisprudence ; Costs and Cost Analysis ; Drug Costs ; Drug Industry/economics ; Drug Industry/legislation & jurisprudence ; Economic Competition ; Economics, Pharmaceutical/legislation & jurisprudence ; Economics, Pharmaceutical/trends ; Humans ; International Cooperation ; World Health Organization
    Language English
    Publishing date 2020-01-11
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 1100273-6
    ISSN 1179-2027 ; 1170-7690
    ISSN (online) 1179-2027
    ISSN 1170-7690
    DOI 10.1007/s40273-019-00877-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3579: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Australia's National Medicines Policy is outdated and in need of review.

    Shaw, Brendan / Chisholm, Orin

    The Medical journal of Australia

    2019  Volume 211, Issue 6, Page(s) 252–254.e1

    MeSH term(s) Australia ; Drug Industry/legislation & jurisprudence ; Drug Industry/organization & administration ; Drug Industry/standards ; Health Policy ; History, 20th Century ; History, 21st Century ; Humans ; Legislation, Drug/history ; Legislation, Drug/organization & administration ; Legislation, Drug/standards ; Public Health
    Language English
    Publishing date 2019-07-21
    Publishing country Australia
    Document type Historical Article ; Journal Article
    ZDB-ID 186082-3
    ISSN 1326-5377 ; 0025-729X
    ISSN (online) 1326-5377
    ISSN 0025-729X
    DOI 10.5694/mja2.50268
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.398: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Book ; Online: Innovation policy instruments (non-price) for medical innovation

    Mestre-Ferrandiz, Jorge, Shaw, Brendan, Chatterjee, Chirantan, Ding, Jin, Singh, Preeti, Hopkins, Michael M.

    2022  

    Abstract: ix, 50 p. ... Innovation policy instruments are policy interventions with a specific mechanism of action that influences the innovation process. This Oslo Medicines Initiative technical report presents a broad range of such instruments available to ... ...

    Abstract ix, 50 p.

    Innovation policy instruments are policy interventions with a specific mechanism of action that influences the innovation process. This Oslo Medicines Initiative technical report presents a broad range of such instruments available to national policy-makers in support of innovation for new medicines (excluding those focused on price, which are covered elsewhere in the report series). This report explores various types of policy instrument, based on reviews of the literature on policies for innovation in the medical and other sectors. For each type identified, the report explores the mechanisms of action, the effects these have and where they occur, and the extent to which these instruments have been implemented globally. It also sets out considerations for their effective implementation. The report demonstrates that the long-established push/pull (supply/demand) framing that dominates discourse around medical innovation can be broadened, providing policy-makers with instruments to supplement push/pull approaches, by emphasizing the role of communication, collaboration and coordination in supporting the emergence of medicines to address societal needs.
    Keywords Policy Making ; Medicine ; Communication ; Pharmacy Administration
    Language English
    Publisher World Health Organization. Regional Office for Europe
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Book ; Online: Инструменты политики (не связанные с ценовыми факторами) в поддержку инноваций в области медицины

    Shaw, Brendan, / Chatterjee, Chirantan / Ding, Jin / Singh, Preeti / Hopkins, Michael M. / Mestre-Ferrandiz, Jorge

    Технический доклад Инициативы Осло по лекарственным средствам: основные положения.

    2022  

    Abstract: 5 с. ... Под инструментами инновационной политики имеются в виду вмешательства в сферу политики с особым механизмом действия, который оказывает влияние на процесс нововведений. В техническом докладе Инициативы Осло по лекарственным средствам представлен ... ...

    Abstract 5 с.

    Под инструментами инновационной политики имеются в виду вмешательства в сферу политики с особым механизмом действия, который оказывает влияние на процесс нововведений. В техническом докладе Инициативы Осло по лекарственным средствам представлен широкий диапазон таких инструментов для использования национальными органами, отвечающими за формирование политики, в поддержку инноваций в области новых лекарственных препаратов (за исключением тех, которые ориентированы на факторы цены, о чем говорится в других материалах серии докладов). Этот доклад посвящен анализу различных типов инструментов политики, проведенному в результате обзора литературных источников по вопросам инновационной политики в медицинском и других секторах. По каждому из этих типов в отчете дается описание их механизмов действий, характера воздействия и в чем он проявляется, а также уточняется размах внедрения этих инструментов в практику в глобальном масштабе. Здесь также изложены соображения по эффективному осуществлению таких механизмов. Доклад наглядно показывает, что давно сложившуюся пуш/пул-конструкцию (соотношение спроса и предложения), занимающую доминирующее положение в связи с полемикой вокруг нововведений в области медицины, можно расширить, вооружив определяющих политику лиц инструментами в дополнение к пуш/пул-подходам через актуализацию функции коммуникации, сотрудничества и координации в процессе содействия появлению новых лекарственных средств для удовлетворения потребностей населения.
    Keywords Health Policy ; Pharmaceutical products ; Medicine
    Language Russian
    Publisher Всемирная организация здравоохранения. Европейское региональное бюро
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  6. Article: Economic governance and a coordination rationale for the state

    Shaw, Brendan / Hughes, Owen E

    Economic governance & institutional dynamics , p. 200-225

    the case of industry policy

    2002  , Page(s) 200–225

    Author's details Brendan Shaw and Owen Hughes
    Keywords 50
    Language English
    Publisher Oxford Univ. Press
    Publishing place South Melbourne, Victoria [u.a.]
    Document type Article
    ISBN 0-19-551543-9 ; 978-0-19-551543-5
    Database ECONomics Information System

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  7. Book: Australia's wine industry

    Marsh, Ian / Shaw, Brendan

    collaboration and learning as causes of competitive success

    2000  

    Author's details Ian Marsh & Brendan Shaw
    Keywords Wine industry/Economic aspects ; Wine and wine making/Economic aspects
    Language English
    Size 66 p. :, ill. ;, 29 cm.
    Publisher Australian Business Foundation
    Publishing place Sydney, NSW
    Document type Book
    Note "May 2000."
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  8. Book: A cross-national comparison of government assistance for industrial R&D

    Birch, Chris / Shaw, Brendan

    (Working paper : Bureau of Industry Economics ; 90)

    1993  

    Author's details Chris Birch and Brendan Shaw
    Series title Working paper : Bureau of Industry Economics ; 90
    Keywords Technologiepolitik ; Industrieforschung ; Forschungsfinanzierung ; Australien ; USA ; Kanada ; Frankreich ; Singapur ; Welt ; 14*41*24*42*34*43*15*51*25*52*35*53*16*61*26*62*36*63*18*81*28*82*38*83*19*29*39
    Language English
    Size III, 52 S. : graph. Darst
    Document type Book
    Note Literaturverz. S. 49 - 52
    Database ECONomics Information System

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  9. Book: The impact of the 150 % R&D tax concession on the use of existing research infrastructure

    Chapman, David / Shaw, Brendan

    (Working paper : Bureau of Industry Economics ; 89)

    1993  

    Author's details David Chapman and Brendan Shaw
    Series title Working paper : Bureau of Industry Economics ; 89
    Keywords Steuervergünstigung ; Industrieforschung ; Forschung ; Australien ; 14*41*24*42*34*43
    Language English
    Size 79 S
    Document type Book
    Note Literaturverz. S. 79
    Database ECONomics Information System

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top